resmed inc (RMD) Key Developments
ResMed Launches AirSense 10 Autoset for Her: a Complete Integrated Sleep Solution for Women Living with Sleep Apnoea
Mar 6 15
ResMed Inc. has announced the European launch of the AirSense 10 AutoSet for Her, the first range of treatments designed to provide an integrated sleep solution specifically for women living with obstructive sleep apnoea (OSA). Featuring built-in wireless connectivity and advanced comfort technologies, the AutoSet for Her delivers a unique, clinically proven, auto-adjusting algorithm designed to treat mild-to-moderate sleep apnoea in women. To complement the AirSense 10 AutoSet for Her device, is the newly launched range of ultra-light and compact masks, the AirFit for Her offering the perfect fit tailored to the female anatomy.
ResMed's AirView Patient Management System to Directly Integrate with Brightree's Home Medical Equipment Billing and Business Management Software Solution
Feb 2 15
ResMed and Brightree announced ResMed's AirView patient management system will directly integrate with Brightree's leading home medical equipment (HME) billing and business management software solution. The AirView-Brightree integration is the latest connectivity achievement in ResMed and Brightree's longstanding relationship, and is one of multiple enhancements planned for this year. Past advances have included Brightree integration with ResMed's U-Sleep® premium sleep compliance solution, as well as a data exchange agreement allowing HMEs to order ResMed equipment directly from the Brightree platform. This direct integration was made possible by the ResMed Data Exchange program, a comprehensive suite of software and service solutions that allows for the integration of valuable sleep and respiratory treatment data from ResMed's AirView and U-Sleep patient management platforms with electronic medical records, billing, and care management applications. AirView and U-Sleep are part of the ResMed Air Solutions suite of sleep and respiratory products that provide physicians, HMEs and patients with the tools and data that can support improved workflow efficiencies and patient outcomes.
ResMed Inc. Presents at Leerink's Global Healthcare Conference, Feb-12-2015 08:05 AM
Jan 30 15
ResMed Inc. Presents at Leerink's Global Healthcare Conference, Feb-12-2015 08:05 AM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: David Pendarvis, Chief Administrative Officer, Global General Counsel and Secretary.
ResMed Inc. Declares Quarterly Dividend, Payable on March 19, 2015
Jan 22 15
ResMed Inc. declared a quarterly dividend of $0.28 per share, with a record date of February 12, 2015 and payable on March 19, 2015.
ResMed Inc. Reports Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended December 31, 2014
Jan 22 15
ResMed Inc. reported unaudited consolidated earnings results for second quarter and six months ended December 31, 2014. For the quarter, the company reported net revenue of $422,952,000 against $384,341,000 a year ago. Income from operations was $109,146,000 against $105,020,000 a year ago. Income before income tax was $115,511,000 against $109,461,000 a year ago. Net income was $91,181,000 against $86,636,000 a year ago. Diluted earnings per share were $0.64 against $0.60 a year ago. Cash flow from operations was $106.0 million.
For the six months, the company’s net revenue was $803,351,000 against $742,003,000 a year ago. Income from operations was $203,821,000 against $201,903,000 a year ago. Income before income tax was $217,441,000 against $211,530,000 a year ago. Net income was $174,440,000 against $167,566,000 a year ago. Diluted earnings per share were $1.22 against $1.15 a year ago. Net cash provided by operating activities was $192,538,000 against $174,590,000 a year ago. Purchase of property, plant and equipment was $39,675,000 against $36,426,000 a year ago.